Dk Sinopharma Inc. (GREY:DKSP)

Tuesday, June 21, 2016 | Web News
Item 1.01 Entry Into a Material Definitive Agreement Item 2.03 Creation of a Direct Financial Obligation Item 3.02 Unregistered Sales of Equity Securities...
Monday, May 16, 2016 | Web News
VGambling Inc. Statement of Expenses (Unaudited) >
Friday, November 13, 2015 | Web News
VGambling Inc. Consolidated Statement of Operations (Unaudited) >
See All Research...

At least one VIE exists in the corporate structure

Our business focuses on the development and sale of pharmaceutical products and over the counter products based on traditional Chinese medicines (“TCMs”) designed to address varying diseases and conditions. Since most of our products are derived from TCMs, our primary raw materials used to manufacture our products are various types of medicinal herbs. We also enter into trading agreements for the supply of many of the materials used to manufacture and package our products including aluminum foil, which we use as the inner packing materials in tablets production. Maidisen has written agreements with all of its suppliers.

Our focus has been on the development and sale of pharmaceutical products based on traditional Chinese medicines (“TCMs”) designed to address numerous diseases and indications, with an emphasis on sales to community hospitals and rural medical institutions.

Reverse Merger Filing

Last updated May 22, 2010


Market Data powered by QuoteMedia. Terms of Use